ANDA 76335, held by Ph Health. Ethinyl Estradiol; Norgestimate.
As of Nov 16, 2026, ANDA 76335 (Tri-Previfem), held by Ph Health, was first approved by FDA on Mar 26, 2004, with 6 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 26, 2004 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Tri-Previfem0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG · tablet;oral-28 | Ethinyl Estradiol; Norgestimate | Discontinued |
| Apr 29, 2022 | Supplement 21Labeling · Standard review | Approved | None posted |
| Feb 3, 2022 | Supplement 20Labeling · Standard review | Approved | None posted |
| Feb 24, 2016 | Supplement 16Manufacturing | Approved | None posted |
| Feb 24, 2016 | Supplement 19Labeling · Standard review | Approved | None posted |
| Dec 19, 2014 | Supplement 17Labeling · Standard review | Approved | None posted |
| Jan 3, 2013 | Supplement 14Labeling · Standard review | Approved | None posted |
| Mar 26, 2004 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters